Detalles de la búsqueda
1.
Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
Clin Infect Dis
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552208
2.
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
Br J Clin Pharmacol
; 89(4): 1318-1328, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680782
3.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Crit Care
; 27(1): 9, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627655
4.
Dibenzocyclooctynes: Effect of Aryl Substitution on Their Reactivity toward Strain-Promoted Alkyne-Azide Cycloaddition.
J Org Chem
; 84(13): 8542-8551, 2019 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31199143
5.
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.
Contemp Clin Trials
; 131: 107267, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302469
6.
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
J Infect
; 88(3): 106120, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367705
Resultados
1 -
6
de 6
1
Próxima >
>>